Pharmacologic stress echocardiography in the assessment of coronary artery disease

Eugenio Picano, Maria Giovanna Trivieri

Research output: Contribution to journalArticlepeer-review

21 Scopus citations

Abstract

Pharmacologic stress echocardiography has gained widespread popularity in recent years because it is more feasible for the patient and less technically demanding for the echocardiographer than exercise stress testing. The two most popular pharmacologic stresses are dobutamine and dipyridamole. These agents provide similar prognostic value and diagnostic accuracy for angiographically assessed coronary artery disease; dobutamine has marginally higher sensitivity in single-vessel disease, and dipyridamole has marginally higher specificity in patients with normal coronary arteries. Both stresses are safe, but a physician should always be in attendance when they are administered: Life-threatening reactions can occur in one of 300 to 500 cases with dobutamine and in one of 700 to 1500 cases with dipyridamole. For dipyridamole and dobutamine echocardiography, outcome data are available from multicenter, international, observational, prospective studies, such as the EPIC (Echo Persantine International Cooperative) and EDIC (Echo Dobutamine International Cooperative) studies.

Original languageEnglish
Pages (from-to)464-470
Number of pages7
JournalCurrent Opinion in Cardiology
Volume14
Issue number6
DOIs
StatePublished - 1999
Externally publishedYes

Fingerprint

Dive into the research topics of 'Pharmacologic stress echocardiography in the assessment of coronary artery disease'. Together they form a unique fingerprint.

Cite this